Related Experiment Video
Updated: Nov 24, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Adverse neonatal outcomes associated with pregestational diabetes mellitus in infants born preterm
Beverly C Tse1, Barry Block1, Heather Figueroa1
1Department of Obstetrics and Gynecology, Loma Linda University School of Medicine, Loma Linda, CA.
Insights
Infants born preterm to mothers with pregestational diabetes mellitus face increased risks of infant death, NICU admission, and other complications. This highlights the importance of managing diabetes during pregnancy for better neonatal outcomes.
Area of Science:
- Neonatal health
- Maternal-fetal medicine
- Endocrinology
Background:
- Pregestational diabetes mellitus (PGDM) is linked to adverse pregnancy outcomes.
- The specific risks for preterm infants born to mothers with PGDM remain unclear.
Purpose of the Study:
- To quantify neonatal complications in preterm infants born to mothers with PGDM.
- To compare outcomes between preterm infants with and without maternal PGDM.
Main Methods:
- Retrospective cohort study of singleton neonates born in Texas (2006-2014).
- Analysis included births between 24-36 weeks gestation, excluding anomalies and multiple births.
- Multivariate logistic regression controlled for confounding variables.
Main Results:
- PGDM was associated with increased risk of infant death, low Apgar score, prolonged ventilation, surfactant use, and NICU admission in preterm infants.
- Neonates born before 34 weeks had higher risks of ventilation, NICU admission, and seizures.
- Late preterm infants (34-36 weeks) showed increased risks for low Apgar, ventilation, surfactant, and NICU admission.
Conclusions:
- PGDM significantly increases the risk of adverse neonatal outcomes for preterm infants.
- These findings underscore the need for vigilant monitoring and management of pregnancies complicated by PGDM.
Background:
Pregestational diabetes mellitus is associated with a higher risk of adverse pregnancy outcomes. Based on the available data, it is unclear whether infants born preterm to mothers with pregestational diabetes mellitus are at a higher risk of adverse outcomes than other preterm infants.
Objective:
This study aimed to quantify the neonatal complications associated with pregestational diabetes mellitus in infants born preterm.
Study Design:
This was a retrospective cohort study of all nonanomalous singleton neonates born in Texas from 2006 to 2014. Analysis was limited to births between 24 and 36 weeks' gestation and excluded multiple births, stillbirths, fetal congenital anomalies, neonates born to mothers with gestational diabetes mellitus, and neonates born to mothers with chronic hypertension. Results were stratified by pregestational diabetes mellitus status. Neonatal outcomes of interest included infant death, neonatal intensive care unit admission, low 5-minute Apgar scores, assisted ventilation of >6 hours, surfactant administration, and seizures. Multivariate logistic regression analysis was performed to estimate the association between pregestational diabetes mellitus and neonatal outcomes controlling for potential confounding variables.
Results:
After predefined exclusions, 277,210 births were analyzed, 4164 of which were to mothers with pregestational diabetes mellitus. The comparison group consisted of mothers without pregestational diabetes mellitus. The preterm infant mortality rates between the pregestational diabetic and nondiabetic groups were similar. However, after adjusting for confounding variables, there was an increased risk of infant mortality for preterm neonates born to mothers with pregestational diabetes mellitus. In infants born preterm, pregestational diabetes mellitus was associated with an increased risk of infant death, low 5-minute Apgar score, prolonged assisted ventilation, surfactant requirement, and neonatal intensive care unit admission. Neonates born before 34 weeks' gestation had an increased risk of assisted ventilation of >6 hours, neonatal intensive care unit admission, and seizure. Neonates born to mothers with pregestational diabetes mellitus in the late preterm period between 34 and 36 weeks' gestation had an increased risk of low Apgar score at 5 minutes, assisted ventilation of >6 hours, surfactant use, and neonatal intensive care unit admission.
Conclusion:
Pregestational diabetes mellitus is associated with a higher risk of adverse neonatal outcomes in infants born preterm.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Teratogenicity
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Inborn Errors of Metabolism

